In this study, the loss-of-function experiments manifested that silencing of KIF21B suppressed the proliferation of H1299 and A549 cells, and inhibited NSCLC tumor growth in vivo, which was consistent with the proliferation promoting effect of KIF21B in hepatocellular carcinoma cells. The gene discussed is KIF21B; the disease is neoplasm.